National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held of the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public via teleconference; a public comment session will be held during the meeting.
The meeting will be held on June 25, 2018, from 2:00 p.m. to 4:30 p.m. EST. The confirmed meeting times and agenda will be posted on the NVAC website at http://www.hhs.gov/nvpo/nvac/meetings/index.html as soon as they become available.
Instructions regarding attending this meeting will be posted one week prior to the meeting at: http://www.hhs.gov/nvpo/nvac/meetings/index.html. Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/index.html.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Captain Angela Shen, National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. Phone: (202) 690-5566; email: firstname.lastname@example.org.
End Further Info
Start Supplemental Information
Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program's responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program.
The public meeting will include a presentation from the HPV Implementation Working Group on its findings and draft recommendations for strengthening the effectiveness of national, state, and local efforts to improve HPV coverage rates. The presentation will be followed by Committee deliberation and a vote. The public meeting will also include a presentation on the recent HHS report, “Encouraging Vaccine Innovation: Promoting the Development of Vaccines that Minimize the Burden of Infectious Diseases in the 21st Century,” which was submitted to Congress in accordance with provisions in the 21st Century Cures Act. All agenda items are tentative and subject to change. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website: http://www.hhs.gov/nvpo/nvac/index.html.
Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office (email@example.com) at least five business days prior to the meeting.
Start Printed Page 21786
End Supplemental Information
Dated: May 7, 2018.
Deputy Director, National Vaccine Program Office.
[FR Doc. 2018-09947 Filed 5-9-18; 8:45 am]
BILLING CODE 4150-44-P